These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12220254)

  • 1. The German experience with NAT.
    Roth WK; Seifried E
    Transfus Med; 2002 Aug; 12(4):255-8. PubMed ID: 12220254
    [No Abstract]   [Full Text] [Related]  

  • 2. Scottish experience with NAT.
    Jarvis LM; Simmonds P
    Transfus Med; 2002 Aug; 12(4):259-64. PubMed ID: 12220255
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleic acid testing for blood banks: an experience from a tertiary care centre in New Delhi, India.
    Agarwal N; Chatterjee K; Coshic P; Borgohain M
    Transfus Apher Sci; 2013 Dec; 49(3):482-4. PubMed ID: 23541414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual detection of multiple viral amplicons by dipstick assay: its application in screening of blood donors a welcome tool for the limited resource settings.
    Panhotra BR; Hassan ZU; Joshi CS; Bahrani A
    J Clin Microbiol; 2005 Dec; 43(12):6218; author reply 6218-9. PubMed ID: 16333138
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM; Unkelbach U; Chudy M; Seitz R
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US NAT yield: where are we after 2 years?
    Stramer SL
    Transfus Med; 2002 Aug; 12(4):243-53. PubMed ID: 12220253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.
    Chatterjee K; Coshic P; Borgohain M; Premchand ; Thapliyal RM; Chakroborty S; Sunder S
    Natl Med J India; 2012; 25(4):207-9. PubMed ID: 23278777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of genome amplification technology for HCV RNA detection.
    Eglin R
    Transfus Med; 2002 Aug; 12(4):265-73. PubMed ID: 12220256
    [No Abstract]   [Full Text] [Related]  

  • 10. External quality assessment programmes for detection of HCV RNA, HIV RNA and HBV DNA in plasma: improved proficiency of the participants observed over a 2-year period.
    Pisani G; Cristiano K; Marino F; Luciani F; Bisso GM; Gaggioli A; Mele C; Pupella S; Grazzini G; Wirz M
    Vox Sang; 2010 Nov; 99(4):319-24. PubMed ID: 20609209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardization: a progress report.
    Saldanha J
    Biologicals; 1999 Dec; 27(4):285-9. PubMed ID: 10686054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an automated high-volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment.
    Hourfar MK; Schmidt M; Seifried E; Roth WK
    Vox Sang; 2005 Aug; 89(2):71-6. PubMed ID: 16101686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
    Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
    Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P; Wessberg S; Tuomi K; Laitinen H
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
    Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
    Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in postmortem blood specimens using infectious disease assays licensed for cadaveric donor screening.
    Greenwald MA; Kerby S; Francis K; Noller AC; Gormley WT; Biswas R; Forshee RA
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT for HBV and anti-HBc testing increase blood safety.
    Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E
    Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
    Laperche S
    Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.
    Coste J; Reesink HW; Engelfriet CP; Laperche S; Brown S; Busch MP; Cuijpers HT; Elgin R; Ekermo B; Epstein JS; Flesland O; Heier HE; Henn G; Hernandez JM; Hewlett IK; Hyland C; Keller AJ; Krusius T; Levicnik-Stezina S; Levy G; Lin CK; Margaritis AR; Muylle L; Niederhauser C; Pastila S; Pillonel J; Pineau J; van der Poel CL; Politis C; Roth WK; Sauleda S; Seed CR; Sondag-Thull D; Stramer SL; Strong M; Vamvakas EC; Velati C; Vesga MA; Zanetti A
    Vox Sang; 2005 May; 88(4):289-303. PubMed ID: 15877653
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets.
    Chudy M; Weber-Schehl M; Pichl L; Jork C; Kress J; Heiden M; Funk MB; Nübling CM
    Transfusion; 2012 Feb; 52(2):431-9. PubMed ID: 21810100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.